Given the profound and unprecedented effects of PIP4K2A on tumor growth inhibition in vitro and in vivo through regulating PI3K signaling via p85/p110 component degradation, we highlight the newly discovered role of PIP4K2A in GBM. The gene discussed is PIK3R2; the disease is neoplasm.